AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2012
Oct 25, 2012
32939_dirs_2012-10-25_9d850ac3-fbe5-4498-9f5f-330f821b7f68.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2012-10-23
Reporting Person: SOTO JOHN (SVP - Global Franchise Leader)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-10-23 | Common Stock | A | 10000 | — | Acquired | 10000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-10-23 | Non-Qualified Stock Option (right to buy) | $10.37 | A | 50000 | Acquired | 2019-10-23 | Common Stock (50000) | Direct |
Footnotes
F1: The acquisition of 10,000 shares of common stock represents 10,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal installments beginning on 9/10/2013.
F2: Options for 25% of the shares are each exercisable on 9/10/2013, 9/10/2014, 9/10/2015 and 9/10/2016, respectively.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 6